Differing national interpretations of the IVD (in vitro diagnostic) Directive will test manufacturers' ability to comply
This article was originally published in Clinica
The Medical Devices Directive was supposed to create a single European regulatory environment for such products throughout the European Economic Area. But differences in the way individual health authorities have transposed it mean that in practice requirements for manufacturers can vary considerably from country to country. The same will be true of the In Vitro Diagnostics Directive, which has technically just come into force. Maureen Kenny reports.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.
Private Company Edition: While venture capital invested in the industry dropped in 2019, the number of deals rose as investors funded more early-stage VC rounds. Money continues flowing to large deals as well, including $105m for ALX Oncology and $98m for CANbridge.